Aadi Bioscience Inc. (AADI)
Aadi Bioscience Statistics
Share Statistics
Aadi Bioscience has 46.29M shares outstanding. The number of shares has increased by 88.52% in one year.
| Shares Outstanding | 46.29M |
| Shares Change (YoY) | 88.52% |
| Shares Change (QoQ) | 87.55% |
| Owned by Institutions (%) | 55.34% |
| Shares Floating | 8.31M |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.34 and the forward PE ratio is null. Aadi Bioscience's PEG ratio is 0.41.
| PE Ratio | -1.34 |
| Forward PE | n/a |
| PS Ratio | 3.28 |
| Forward PS | 1.6 |
| PB Ratio | 1.63 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.41 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aadi Bioscience.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.59 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | - |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $490.25K |
| Profits Per Employee | $-1.2M |
| Employee Count | 53 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 0.57 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 11.41% in the last 52 weeks. The beta is 0.34, so Aadi Bioscience's price volatility has been higher than the market average.
| Beta | 0.34 |
| 52-Week Price Change | 11.41% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 37.54 |
| Average Volume (20 Days) | 200.71K |
Income Statement
In the last 12 months, Aadi Bioscience had revenue of 25.98M and earned -63.69M in profits. Earnings per share was -2.36.
| Revenue | 25.98M |
| Gross Profit | 22.96M |
| Operating Income | -67.46M |
| Net Income | -63.69M |
| EBITDA | -64.63M |
| EBIT | -64.82M |
| Earnings Per Share (EPS) | -2.36 |
Balance Sheet
The company has 28.67M in cash and 833K in debt, giving a net cash position of 27.84M.
| Cash & Cash Equivalents | 28.67M |
| Total Debt | 833K |
| Net Cash | 27.84M |
| Retained Earnings | -332.65M |
| Total Assets | 70.32M |
| Working Capital | 44.21M |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 88.36%, with operating and profit margins of -259.62% and -245.13%.
| Gross Margin | 88.36% |
| Operating Margin | -259.62% |
| Pretax Margin | -245.13% |
| Profit Margin | -245.13% |
| EBITDA Margin | -248.72% |
| EBIT Margin | -259.62% |
| FCF Margin | n/a |
Dividends & Yields
AADI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AADI is $1.75, which is -14.6% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.75 |
| Price Target Difference | -14.6% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Aug 27, 2021. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -5.32 |
| Piotroski F-Score | 3 |